Catalytic domain 1.10.510.10 :CatDom of EzCatDB EzCatDB

CatDom: Enzyme Catalytic Domains based on CATH classification

Top page of CatDom: EzCatDB


C 1.-.-.- : Mainly Alpha (Class)

A 1.10.-.- : Orthogonal Bundle (Architecture)

T 1.10.510.- : Transferase(Phosphotransferase); domain 1 (Topology)

H 1.10.510.10 : Transferase(Phosphotransferase) domain 1 (Homologous Superfamily)


Related Enzymes

There are 26 entries in this class.
  • M00124 : 2.7.10.1; Ephrin type-B receptor 2
  • M00125 : 2.7.11.15; Beta-adrenergic receptor kinase 1
  • M00127 : 2.7.10.1; Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr)AltName: CD_antigen=CD331;
  • M00129 : 2.7.10.1; Insulin receptor (IR) (EC 2.7.10.1)AltName: CD_antigen=CD220;
  • M00130 : 2.7.10.2; Tyrosine-protein kinase ABL1
  • M00131 : 2.7.10.1; Vascular endothelial growth factor receptor 1
  • M00132 : 2.7.10.1; High affinity nerve growth factor receptor
  • M00136 : 2.7.10.1; Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor)AltName: CD_antigen=CD221;
  • M00196 : 2.7.11.22; Cyclin-dependent kinase 5
  • M00197 : 2.7.11.1; Casein kinase II subunit alpha
  • M00198 : 2.7.11.19; Phosphorylase b kinase regulatory subunit alpha
  • M00304 : 2.7.10.2; Tyrosine-protein kinase CSK
  • M00323 : 2.7.10.1; Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Piebald trait protein) (PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog)AltName: CD_antigen=CD117;
  • M00325 : 2.7.10.1; Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK)AltName: CD_antigen=CD202b;
  • M00326 : 2.7.10.1; Proto-oncogene tyrosine-protein kinase receptor Ret
  • M00327 : 2.7.10.1; Muscle
  • M00328 : 2.7.10.1; ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase)AltName: CD_antigen=CD246;
  • M00329 : 2.7.10.1; Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (CDw136) (Protein-tyrosine kinase 8) (p185-Ron)AltName: CD_antigen=CD136;
  • M00330 : 2.7.10.1; Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms)AltName: CD_antigen=CD115;
  • M00331 : 2.7.10.1; Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1)AltName: CD_antigen=CD135;
  • M00332 : 2.7.10.1; Tyrosine-protein kinase Mer
  • M00333 : 2.7.10.2; Tyrosine-protein kinase ZAP-70
  • M00335 : 2.7.10.2, 2.7.11.1; Activated CDC42 kinase 1
  • M00339 : 2.7.10.2; Tyrosine-protein kinase Fes/Fps
  • M00344 : 2.7.10.2; Cytoplasmic tyrosine-protein kinase BMX
  • T00224 : 2.7.11.30; TGF-beta receptor type-1
  • Copyright: Nozomi Nagano, JST & CBRC-AIST
    Funded by PRESTO/Japan Science and Technology Agency (JST) (December 2001 - November 2004)
    Funded by Grant-in-Aid for Publication of Scientific Research Results/Japan Society for the Promotion of Science (JSPS) (April 2005 - March 2006)
    Funded by Grant-in-Aid for Scientific Research (B)/Japan Society for the Promotion of Science (JSPS) (April 2005 - March 2008)
    Funded by BIRD/Japan Science and Technology Agency (JST) (September 2005 - September 2008)
    Funded by BIRD/Japan Science and Technology Agency (JST) (October 2007 - September 2010)
    Funded by Grant-in-Aid for Publication of Scientific Research Results/Japan Society for the Promotion of Science (JSPS) (April 2011 - March 2012)
    Funded by Grant-in-Aid for Publication of Scientific Research Results/Japan Society for the Promotion of Science (JSPS) (April 2012 - March 2013)
    Supported by the commission for the Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI) (October 2012 - )